[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336044-105":59,"doc-detail-336044-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","non-coding-rna-transcripts-incredible-modulators-of-cisplatin-chemo-resistance-in-bladder-cancer-through-operating-a-broad-spectrum-of-cellular-processes-and-signaling-mechanism-review-focus","Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism - Review focus","","Bladder cancer (BC) is a frequent malignancy associated with high morbidity, mortality, and treatment cost, often driven by carcinogenic environmental or occupational exposures. Two development routes are described: non-muscle-invasive papillary tumors and non-papillary muscle-invasive tumors. Cisplatin is widely regarded as the most effective chemotherapy, yet recurrence commonly follows due to acquired chemo-resistant traits. Non-coding RNAs including microRNAs, long non-coding RNAs, and circular RNAs can regulate signaling and cellular processes that shape cisplatin resistance. The review highlights diagnostic, prognostic, and therapeutic potential of these ncRNAs in BC management.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/non-coding-rna-transcripts-incredible-modulators-of-cisplatin-chemo-resistance-in-bladder-cancer-through-operating-a-broad-spectrum-of-cellular-processes-and-signaling-mechanism-review-focus/336044/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/non-coding-rna-transcripts-incredible-modulators-of-cisplatin-chemo-resistance-in-bladder-cancer-through-operating-a-broad-spectrum-of-cellular-processes-and-signaling-mechanism-review-focus/336044.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why does bladder cancer commonly recur after cisplatin treatment?","Question",{"text":113,"@type":114},"Recurrence often occurs after cisplatin regimens due to progression of chemo-resistant traits.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which types of non-coding RNAs are discussed as mediators of cisplatin resistance?",{"text":118,"@type":114},"The review focuses on microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs).",{"name":120,"@type":111,"acceptedAnswer":121},"How can non-coding RNAs contribute to cisplatin chemo-resistance in bladder cancer?",{"text":122,"@type":114},"They may mediate the cisplatin-resistant phenotype through diverse cellular processes and signaling mechanisms.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},336044,1790106380,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Non-coding RNA Research 9 (2024) 560–582  \nContents lists available at ScienceDirect  \nNon-coding RNA Research  \njournal [homepage:](homepage: www.keaipublishing.com/en/journals/non-coding-rna-research)[ www.keaipublishing.com/en/journals/non-coding-rna-research](homepage: www.keaipublishing.com/en/journals/non-coding-rna-research)  \n| Non-coding RNA transcripts, incredible modulators of cisplatin  chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism |  |  |  |\n| --- | --- | --- | --- |\n| Mehrdad Hashema, b, Elaheh Mohandesi Khosroshahi a, b, Melika Aliahmadyb, Morvarid Ghaneib, Yasamin Soofi Rezaieb, Yasamin alsadat Jafarib, c, Fatemeh rezaeib, c, Ramtin Khodaparast eskadehib, c, Kimia Kia Kojoorib, c, faranak jamshidian b, c,\u003Cbr>Noushin Nabavid, Mohsen Rashidie, f, **, Farzaneh Hasani Sadig, ***, Afshin Taheriazamb, h, Maliheh Entezaria, b, *\u003Cbr>a Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran b Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran c Department of Biology, East Tehran Branch, Islamic Azad University, Tehran, Iran\u003Cbr>d Department of Urologic Sciences and Vancouver Prostate Centre, University of British Columbia, V6H3Z6, Vancouver, BC, Canada e The Health of Plant and Livestock Products Research Center, Mazandaran University of Medical Sciences, Sari, Iran f Department Pharmacology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran\u003Cbr>g General Practitioner, Kerman University of Medical Sciences, Kerman, 7616913555, Iran\u003Cbr>h Department of Orthopedics, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran |  |  | ****\u003Cbr>, |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>Urinary bladder neoplasms Cisplatin\u003Cbr>Drug resistance Non-coding RNAs Signal transduction |  | Bladder cancer (BC) is a highly frequent neoplasm in correlation with significant rate of morbidity, mortality, and cost. The onset of BC is predominantly triggered by environmental and/or occupational exposures to carcinogens, such as tobacco. There are two distinct pathways by which BC can be developed, including non-muscleinvasive papillary tumors (NMIBC) and non-papillary (or solid) muscle-invasive tumors (MIBC). The Cancer Genome Atlas project has further recognized key genetic drivers of MIBC along with its subtypes with particular properties and therapeutic responses; nonetheless, NMIBC is the predominant BC presentation among the suffering individuals. Radical cystoprostatectomy, radiotherapy, and chemotherapy have been verified to be the common therapeutic interventions in metastatic tumors, among which chemotherapeutics are more conventionally utilized. Although multiple chemo drugs have been broadly administered for BC treatment, cisplatin is reportedly the most effective chemo drug against the corresponding malignancy. Notwithstanding, tumor recurrence is usually occurred following the consumption of cisplatin regimens, particularly due to the progression of chemo-resistant trait. In this framework, non-coding RNAs (ncRNAs), as abundant RNA transcripts arise from the human genome, are introduced to serve as crucial contributors to tumor expansion and cisplatinchemo-resistance in bladder neoplasm. In the current review, we first investigated the best-known ncRNAs, i.e. microRNAs (miRNAs), long ncRNAs (lncRNAs), and circular RNAs (circRNAs), correlated with cisplatin chemoresistance in BC cells and tissues. We noticed that these ncRNAs could mediate the BC-related cisplatin-resistant phenotype through diverse cellular processes and signaling mechanisms, reviewed here. Eventually, diagnostic and prognostic potential of ncRNAs, as well as their therapeutic capabilities were highlighted in regard to BC management. |  |\n\n* Corresponding au","cbCaifCDXKascDA6","https://ap.wps.com/l/cbCaifCDXKascDA6","pdf",5368484,23,"English","# Introduction\n## Cisplatin in bladder cancer therapy\n## Non-coding RNAs and cisplatin resistance\n## ncRNA-based diagnostic, prognostic, and therapeutic potential","[{\"question\":\"Why does bladder cancer commonly recur after cisplatin treatment?\",\"answer\":\"Recurrence often occurs after cisplatin regimens due to progression of chemo-resistant traits.\"},{\"question\":\"Which types of non-coding RNAs are discussed as mediators of cisplatin resistance?\",\"answer\":\"The review focuses on microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs).\"},{\"question\":\"How can non-coding RNAs contribute to cisplatin chemo-resistance in bladder cancer?\",\"answer\":\"They may mediate the cisplatin-resistant phenotype through diverse cellular processes and signaling mechanisms.\"}]","Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism - Review focus | PDF",1790013348,58]